Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

27.05 -0.17 (-0.62%)
Official Closing Price Updated: 4:10 PM EST, Feb 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Pfizer

< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
39 40 Next >
Capturing the U.S. Health Care Space with XLV
Via Get News
Topics ETFs
News headline image
When Does Pfizer Become A Bargain?
With a price-to-earnings ratio of less than 9 and a dividend yield of 3.63% you have to be thinking that Pfizer may a bit of a bargain down here. 
Via MarketBeat
News headline image
Tumor Lysis Syndrome Market Projected to Show Strong Growth : AbbVie, Hikma Pharmaceuticals, Amgen, Genentech
Get an extensive Tumor Lysis Syndrome Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry. 
Via SBWire
News headline image
Is C3.ai Stock a ChatGPT Artificial Intelligence Play?
Via MarketBeat
Topics Artificial Intelligence
News headline image
Moderna and Pfizer Race to Release RSV Vaccines
Two of the largest vaccine producers have engaged in the rapid development of RSV vaccines, here's how the companies are tracking so far. 
Via MarketBeat
News headline image
AbbVie Stock: Dividend King ABBV Overview
Via MarketBeat
News headline image
Drug Delivery Market – Major Technology Giants in Buzz Again : Johnson & Johnson, Sanofi, Pfizer
How to reach that market place and its associated audience with current marketing efforts? Benchmark now the competitive efforts with high growth emerging players and leaders of Drug Delivery Market. 
Via SBWire
News headline image
Health and Beauty Products Market to Eyewitness Massive Growth by 2028 : Wallgreen, Coty, Nestle
Stay up-to-date with Health and Beauty Products Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
News headline image
Johnson & Johnson Breakout Breaks Down: Can Earnings Boost Stock?
Johnson & Johnson stock has been struggling to break out of a correction. It formed a cup-shaped pattern that appeared to add a handle but broke down last week. 
Via MarketBeat
Topics Stocks
News headline image
Pfizer Expands ‘An Accord for a Healthier World’ Product Offering to Include Full Portfolio for Greater Benefit to 1.2 Billion People in 45 Lower-Income Countries
From Pfizer Inc.
Via Business Wire
News headline image
"CDC, FDA…link between Pfizer's shot & strokes" 2 years after FDA warning; Media Failing US: Expert
January 15, 2023 -- FDA's warning of death, strokes, and serious reactions from the shot posted at https://www.fda.gov/media/143557/download pg 16 Oct 22, 2020 were never reported by media, says... 
Via 24-7 Press Release
News headline image
Direct to Consumer Pharmaceutical Advertising Market Is Going to Boom : Pfizer, Merck, GlaxoSmithKline
Stay up-to-date with Direct To Consumer Pharmaceutical Advertising Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Atypical Digital, A Global Digital Marketing Tech Enabled Company, acquires South Korea-based Springworks
Via AB Newswire
News headline image
Four Undervalued Healthcare Stocks for 2023
These four health care stocks could be undervalued: Pfizer Inc., Regeneron Pharmaceuticals Inc., Innoviva Inc. and Exelixis Inc. 
Via MarketBeat
News headline image
A Comprehensive Study Exploring Nephroblastoma Treatment Market: Key Players Bayer HealthCare, Pfizer, AstraZeneca
Get an extensive Nephroblastoma Treatment Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry. 
Via SBWire
News headline image
U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine in Infants and Children
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
From Pfizer Inc.
Via Business Wire
The Year of the Tripledemic
COVID-19 may have lost its daily news headline status, but the disease rages on with 2700 weekly deaths in the U.S. and millions of Americans chronically disabled from long-COVID, 4 million of which... 
Via TheNewswire.com
Topics Death
News headline image
Pfizer Announces Positive Top-Line Results from Phase 3 Study of Hemophilia B Gene Therapy Candidate
From Pfizer Inc.
Via Business Wire
News headline image
Big Health Care Stocks to Watch in the New Year
Here are three health care stocks to watch as the New Year begins. Two have a moderate Buy rating while one is a Hold, for now. 
Via MarketBeat
News headline image
U.S. FDA Accepts for Review the Biologics License Application for Pfizer’s Investigational Pentavalent Meningococcal Vaccine Candidate (MenABCWY) in Adolescents
From Pfizer Inc.
Via Business Wire
News headline image
Why Did Immutep Ltd Stock Soar Recently?
Analysts and investors alike appear enamored with Immutep Ltd, whose earnings are growing; more of which could come from their latest product candidate. 
Via MarketBeat
Topics Initial Public Offering
News headline image
Vaccines & Vaccination Market May Set Epic Growth Story : Pfizer, Merck, Johnson & Johnson
Stay up-to-date with Vaccines & Vaccination Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
News headline image
DeepThink Health Appoints Krish Ghosh as Executive Vice President and General Manager, Life Sciences
Ghosh Brings Three Decades of Life Sciences Experience to DeepThink HealthSAN RAMON, Calif. - Dec. 28, 2022 - PRLog -- DeepThink Health, Inc., an AI-powered leader in the transformation of health data... 
Via PRLog
Topics Artificial Intelligence
News headline image
Pfizer Announces FDA and EMA Acceptance of Etrasimod Regulatory Submissions for Ulcerative Colitis
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Invites Public to View and Listen to Webcast of January 31 Conference Call with Analysts
From Pfizer Inc.
Via Business Wire
News headline image
Eli Lilly Expects Enduring Growth, Despite Immediate Challenges
Eli Lilly & Co may be struggling with supply-side issues but new partnerships and a healthy dividend are helping to keep up their momentum 
Via MarketBeat
News headline image
Pfizer Opts In to LianBio Rights to Respiratory Syncytial Virus Therapeutic Candidate Sisunatovir in Mainland China, Hong Kong, Macau, and Singapore
From LianBio; Pfizer Inc.
Via GlobeNewswire
BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
Small and big pharma companies such as Pfizer Inc. (NYSE: PFE), Celldex Therapeutics Inc. (NASDAQ: CLDX), and Hologic Inc. (NASDAQ: HOLX) are ramping up efforts to help reduce or eliminate the growing... 
Via TheNewswire.com
Topics Death
News headline image
NYSE:PFE Investor Notice: Investigation over Breaches of Fiduciary Duties at Pfizer Inc. ↗
San Diego, CA -- (SBWIRE) -- 12/13/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Pfizer Inc. 
Via SBWire
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
39 40 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.